David A Geller Selected Research

Inflammation (Inflammations)

1/2020	CEACAM1 and molecular signaling pathways to expand the liver transplant donor pool.
12/2013	CD39 expression by hepatic myeloid dendritic cells attenuates inflammation in liver transplant ischemia-reperfusion injury in mice.
5/2009	Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells.
4/2007	A novel inhibitory peptide of Toll-like receptor signaling limits lipopolysaccharide-induced production of inflammatory mediators and enhances survival in mice.
3/2007	Glycochenodeoxycholate (GCDC) inhibits cytokine induced iNOS expression in rat hepatocytes.
1/2007	Increasing numbers of hepatic dendritic cells promote HMGB1-mediated ischemia-reperfusion injury.
7/2006	Regulation of human nitric oxide synthase 2 expression by Wnt beta-catenin signaling.
6/2006	Cutting edge: high-mobility group box 1 preconditioning protects against liver ischemia-reperfusion injury.
12/2005	Hepatic ischemia/reperfusion injury involves functional TLR4 signaling in nonparenchymal cells.
4/2005	The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David A Geller Research Topics

Disease

55	Neoplasms (Cancer) 01/2024 - 05/2005
32	Reperfusion Injury 03/2024 - 07/2002
31	Hepatocellular Carcinoma (Hepatoma) 11/2023 - 12/2005
22	Ischemia 03/2024 - 04/2005
17	Neoplasm Metastasis (Metastasis) 10/2023 - 06/2005
11	Colorectal Neoplasms (Colorectal Cancer) 10/2023 - 08/2003
11	Necrosis 01/2016 - 01/2005
10	Inflammation (Inflammations) 01/2020 - 04/2005
8	Hypoxia (Hypoxemia) 12/2018 - 04/2003
6	Cholangiocarcinoma 10/2021 - 01/2008
5	Pain (Aches) 01/2023 - 05/2010
5	Liver Neoplasms (Liver Cancer) 02/2016 - 01/2006
4	Colonic Neoplasms (Colon Cancer) 01/2022 - 05/2009
4	Disease Progression 01/2021 - 06/2011
3	Margins of Excision 01/2023 - 12/2009
3	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2010
3	Fatigue 01/2020 - 05/2010
3	Fibrosis (Cirrhosis) 05/2017 - 01/2006
3	Hemorrhage 10/2014 - 01/2005
3	Wounds and Injuries (Trauma) 06/2008 - 01/2005
3	Sepsis (Septicemia) 04/2007 - 04/2005
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019 - 12/2012
2	Carcinogenesis 11/2013 - 05/2009
2	Liver Diseases (Liver Disease) 06/2012 - 03/2007
2	Hepatic Insufficiency 07/2011 - 01/2006
2	Gallstones (Gallstone) 03/2011 - 01/2009
2	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 05/2009 - 07/2006
2	Gram-Negative Bacterial Infections 04/2007 - 07/2002
1	Delayed Graft Function 03/2024
1	Lentivirus Infections 01/2024
1	Cancer Pain 01/2023
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021

Drug/Important Bio-Agent (IBA)

14	Interferon Regulatory Factor-1 (Interferon Regulatory Factor 1)IBA 01/2023 - 06/2006
12	CytokinesIBA 01/2023 - 05/2009
10	Proteins (Proteins, Gene)FDA Link 11/2019 - 07/2002
9	Messenger RNA (mRNA)IBA 01/2023 - 12/2011
8	Alanine Transaminase (SGPT)IBA 01/2016 - 08/2005
7	HMGB1 Protein (HMG1)IBA 07/2013 - 04/2005
6	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2023 - 05/2009
6	Transcription Factors (Transcription Factor)IBA 01/2023 - 07/2002
5	Biomarkers (Surrogate Marker)IBA 03/2024 - 05/2010
5	CateninsIBA 06/2021 - 01/2010
5	Carbon MonoxideIBA 12/2011 - 08/2005
4	InterferonsIBA 11/2021 - 01/2012
4	Adenosine Triphosphate (ATP)IBA 10/2020 - 03/2015
3	RNA (Ribonucleic Acid)IBA 01/2024 - 12/2018
3	Immune Checkpoint InhibitorsIBA 11/2021 - 09/2020
3	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 04/2014
3	Interferon Regulatory FactorsIBA 01/2021 - 09/2012
3	MicroRNAs (MicroRNA)IBA 10/2020 - 07/2012
3	Yttrium-90IBA 06/2015 - 11/2008
3	beta CateninIBA 05/2009 - 07/2006
3	NF-kappa B (NF-kB)IBA 05/2009 - 07/2002
2	CEACAM1 ProteinIBA 03/2024 - 01/2020
2	micaIBA 01/2024 - 01/2023
2	Checkpoint Kinase 1IBA 01/2023 - 01/2021
2	Interleukin-6 (Interleukin 6)IBA 01/2023 - 01/2017
2	Deoxyribonucleases (DNase)FDA Link 01/2021 - 11/2019
2	AntigensIBA 04/2014 - 08/2009
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2013 - 07/2006
2	JNK Mitogen-Activated Protein KinasesIBA 07/2013 - 08/2003
2	Toll-Like Receptor 4IBA 07/2013 - 11/2007
2	InterleukinsIBA 06/2012 - 05/2009
2	Narcotics (Narcotic Analgesics)IBA 07/2011 - 12/2010
2	Arginine (L-Arginine)FDA Link 08/2008 - 02/2007
2	ArginaseIBA 08/2008 - 02/2007
2	LipopolysaccharidesIBA 04/2007 - 07/2002
2	Transaminases (Aminotransferases)IBA 10/2006 - 01/2005
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 03/2006 - 08/2005
1	Hypoxia-Inducible Factor 1IBA 03/2024
1	Interferon-gamma (Interferon, gamma)IBA 01/2024
1	Recombinant ProteinsIBA 01/2024
1	Phosphotransferases (Kinase)IBA 01/2023
1	Morphine (MS Contin)FDA LinkGeneric 01/2023
1	Cetuximab (Erbitux)FDA Link 12/2022
1	Interleukin-33IBA 01/2022
1	hydroxide ionIBA 10/2021
1	Indicators and Reagents (Reagents)IBA 06/2021
1	lenvatinibIBA 06/2021
1	Bevacizumab (Avastin)FDA Link 01/2021
1	pembrolizumabIBA 01/2021
1	NivolumabIBA 01/2021

Therapy/Procedure

29	Liver Transplantation 03/2024 - 07/2002
17	Therapeutics 11/2023 - 05/2005
15	Hepatectomy 03/2023 - 11/2009
7	Drug Therapy (Chemotherapy) 12/2022 - 07/2005
5	Radiofrequency Ablation 01/2016 - 08/2008
4	Length of Stay 07/2011 - 01/2009
3	Immunotherapy 01/2022 - 01/2020
3	Palliative Care (Palliative Therapy) 04/2016 - 07/2005
3	Transplantation 10/2011 - 01/2005
2	Neoadjuvant Therapy 01/2021 - 01/2012
2	Metastasectomy 05/2012 - 11/2009
2	Laparoscopic Cholecystectomy 03/2011 - 01/2009
2	Contraindications 03/2011 - 12/2009
2	Warm Ischemia 01/2007 - 12/2005
2	Microspheres (Microsphere) 07/2005 - 06/2005
1	Operative Time 01/2023
1	Segmental Mastectomy (Lumpectomy) 01/2022
1	Operative Surgical Procedures 06/2021